Lotus Eye Hospital & Institute (BOM:532998) Cyclically Adjusted Revenue per Share: ₹25.31 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532998 Lotus Eye Hospital & Institute Ltd BOM:532998
72 GF Score
Price ₹115.95
GF Value ₹98.18
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Lotus Eye Hospital & Institute Cyclically Adjusted Revenue per Share?

Lotus Eye Hospital & Institute BOM:532998 -1.74% 72 Cyclically Adjusted Revenue per Share is ₹25.31 as of Jun. 2026. GuruFocus rates BOM:532998 with a GF Score™ of 72/100 and a GF Value™ of ₹98.18 (Modestly Overvalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Lotus Eye Hospital & Institute's adjusted revenue per share for the three months ended in Jun. 2026 was ₹8.338. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹25.31 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Lotus Eye Hospital & Institute's average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Lotus Eye Hospital & Institute was 4.50% per year. The lowest was 3.90% per year. And the median was 4.10% per year.

As of today (2026-08-20), Lotus Eye Hospital & Institute's current stock price is ₹115.95. Lotus Eye Hospital & Institute's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹25.31. Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio of today is 4.58.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Lotus Eye Hospital & Institute was 5.49. The lowest was 1.43. And the median was 3.05.


Lotus Eye Hospital & Institute  (BOM:532998) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=115.95/25.31
=4.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Lotus Eye Hospital & Institute was 5.49. The lowest was 1.43. And the median was 3.05.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Lotus Eye Hospital & Institute Cyclically Adjusted Revenue per Share Related Terms


Lotus Eye Hospital & Institute Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Lotus Eye Hospital & Institute's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Eye Hospital & Institute Cyclically Adjusted Revenue per Share Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.91 21.87 22.78 23.45 24.66

Lotus Eye Hospital & Institute Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.78 24.17 24.43 24.66 25.31

BOM:532998 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Eye Hospital & Institute Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Lotus Eye Hospital & Institute's Cyclically Adjusted PS Ratio falls into.


BOM:532998
72GF Score
Lotus Eye Hospital & Institute Ltd BOM:532998
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Eye Hospital & Institute Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lotus Eye Hospital & Institute's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=8.338/167.3573*167.3573
=8.338

Current CPI (Jun. 2026) = 167.3573.

Lotus Eye Hospital & Institute Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 4.143 105.961 6.544
201612 3.885 105.196 6.181
201703 4.129 105.196 6.569
201706 4.633 107.109 7.239
201709 4.625 109.021 7.100
201712 4.649 109.404 7.112
201803 4.509 109.786 6.873
201806 4.785 111.317 7.194
201809 3.990 115.142 5.799
201812 4.579 115.142 6.656
201903 4.306 118.202 6.097
201906 5.701 120.880 7.893
201909 5.058 123.175 6.872
201912 4.882 126.235 6.472
202003 3.634 124.705 4.877
202006 2.272 127.000 2.994
202009 3.707 130.118 4.768
202012 4.780 130.889 6.112
202103 4.855 131.771 6.166
202106 2.711 134.084 3.384
202109 5.171 135.847 6.370
202112 5.613 138.161 6.799
202203 4.746 138.822 5.722
202206 5.715 142.347 6.719
202209 5.667 144.661 6.556
202212 5.867 145.763 6.736
202303 4.854 146.865 5.531
202306 6.085 150.280 6.776
202309 6.141 151.492 6.784
202312 5.862 152.924 6.415
202403 4.765 153.035 5.211
202406 6.203 155.789 6.664
202409 6.286 157.882 6.663
202412 5.634 158.323 5.955
202503 5.476 157.552 5.817
202506 6.451 159.755 6.758
202509 6.756 162.289 6.967
202512 6.757 163.281 6.926
202603 6.389 164.272 6.509
202606 8.338 167.357 8.338

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹25.31 mean?
Lotus Eye Hospital & Institute (BOM:532998) has a Cyclically Adjusted Revenue per Share of ₹25.31 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Lotus Eye Hospital & Institute and its competitors.
Is Lotus Eye Hospital & Institute's Cyclically Adjusted Revenue per Share too high?
Lotus Eye Hospital & Institute's current Cyclically Adjusted Revenue per Share is ₹25.31. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Lotus Eye Hospital & Institute's Cyclically Adjusted Revenue per Share of ₹25.31 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Lotus Eye Hospital & Institute and its competitors. Lotus Eye Hospital & Institute's current Cyclically Adjusted Revenue per Share is ₹25.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹98.18, compared to a current price of ₹115.95 — trading 18.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹25.31. Lotus Eye Hospital & Institute's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current Cyclically Adjusted Revenue per Share is ₹25.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued. The current stock price of ₹115.95 is trading 18.1% above its estimated GF Value™ of ₹98.18. GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.

Key valuation signals for BOM:532998:

  • Cyclically Adjusted Revenue per Share: ₹25.31
  • GF Value™: ₹98.18 vs. price of ₹115.95 (18.1% above fair value)
  • GF Score™: 72/100 with 1 warning sign

No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lotus Eye Hospital & Institute Business Description

Other Exchanges LOTUSEYE:India
Address SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
72GF Score

Get the complete analysis for BOM:532998

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹115.95
Price
₹98.18
GF Value